Additionally, the small sample size, 6-months (short) duration of treatment or a potentially mixed pathology (alpha-synuclein, p-tau and Aβ40 and Aβ42 observed in DLB [23,24,25,26] may prevent observation, or lack, of statistical differences between groups. Here, MAPT is linked to Lewy body dementia.